|
(3R,6aS,8R,10aS)-8-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-3-hydroxy-N-(2-methoxyphenyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
|
|
CHEBI:97376
Tanimoto Score: 1.0
Formula: C31H41N3O6
Mass: 551.675
Charge: 0
|
|
|
(3S,6aS,8R,10aS)-8-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-3-hydroxy-N-(2-methoxyphenyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
|
|
CHEBI:97477
Tanimoto Score: 1.0
Formula: C31H41N3O6
Mass: 551.675
Charge: 0
|
|
|
(3S,6aR,8S,10aR)-8-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-3-hydroxy-N-(2-methoxyphenyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
|
|
CHEBI:98166
Tanimoto Score: 1.0
Formula: C31H41N3O6
Mass: 551.675
Charge: 0
|
|
|
(3S,6aR,8R,10aR)-3-hydroxy-N-(2-methoxyphenyl)-8-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
|
|
CHEBI:99988
Tanimoto Score: 1.0
Formula: C31H41N3O6
Mass: 551.675
Charge: 0
|
|
|
(3R,6aR,8R,10aR)-3-hydroxy-N-(2-methoxyphenyl)-8-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
|
|
CHEBI:100642
Tanimoto Score: 1.0
Formula: C31H41N3O6
Mass: 551.675
Charge: 0
|
|
|
(3S,6aS,8S,10aS)-3-hydroxy-N-(2-methoxyphenyl)-8-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
|
|
CHEBI:101176
Tanimoto Score: 1.0
Formula: C31H41N3O6
Mass: 551.675
Charge: 0
|
|
|
(3R,6aS,8S,10aS)-3-hydroxy-N-(2-methoxyphenyl)-8-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
|
|
CHEBI:102652
Tanimoto Score: 1.0
Formula: C31H41N3O6
Mass: 551.675
Charge: 0
|
|
|
(3R,6aR,8S,10aR)-3-hydroxy-N-(2-methoxyphenyl)-8-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
|
|
CHEBI:103006
Tanimoto Score: 1.0
Formula: C31H41N3O6
Mass: 551.675
Charge: 0
|
|
|
|
|
|
|
|
|
| |
| |
|